Status:
NOT_YET_RECRUITING
Implementing WHO HEARTS-D Guidelines in Bangladesh for Diabetes Control and Prevention
Lead Sponsor:
Florida International University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Projahnmo Research Foundation
Conditions:
Type 2 Diabetes (T2DM)
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
Type-2 diabetes (T2D) is rising at an alarming rate in the low- and middle-income countries (LMIC). This rapid increase in the T2D burden has a particular impact on cities, where more than half the LM...
Detailed Description
Background Type-2 diabetes (T2D) is rising at an alarming rate in all low- and middle-income countries (LMIC). This rapid acceleration of the T2D burden has a particular impact on cities, where more t...
Eligibility Criteria
Inclusion
- Adult individuals, ≥35 years of age,
- Of either sex,
- Long-term residents in the study area (defined by being a homeowner or a resident for at least the past three years), and
- Willing to provide informed consent for study procedures and follow-up.
Exclusion
- Individuals planning to migrate from the study area before completing the first 12-month follow-up period, and
- Individuals explicitly requesting exclusion from the study or unable to provide consent.
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2029
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT07155902
Start Date
January 1 2026
End Date
September 1 2029
Last Update
November 6 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.